Shattuck Labs Inc
General ticker "STTK" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $58.5M
Shattuck Labs Inc does not follow the US Stock Market performance with the rate: -34.9%.
Estimated limits based on current volatility of 5.7%: low 1.01$, high 1.14$
Factors to consider:
- Current price 64.9% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.16$, 8.68$]
- 2024-12-30 to 2025-12-30 estimated range: [2.52$, 7.09$]
Financial Metrics affecting the STTK estimates:
- Negative: Non-GAAP EPS, $ of -2.05 <= 0.10
- Negative: Operating profit margin, % of -98.23 <= 1.03
- Negative: Operating cash flow per share per price, % of -32.75 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: negative Net income
Short-term STTK quotes
Long-term STTK plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $30.02MM | $0.65MM | $1.66MM |
| Operating Expenses | $75.29MM | $103.98MM | $93.61MM |
| Operating Income | $-45.27MM | $-103.33MM | $-91.96MM |
| Non-Operating Income | $0.29MM | $1.38MM | $4.66MM |
| R&D Expense | $56.56MM | $82.90MM | $74.31MM |
| Income(Loss) | $-44.97MM | $-101.94MM | $-87.30MM |
| Profit(Loss) | $-44.97MM | $-101.94MM | $-87.30MM |
| Stockholders Equity | $271.79MM | $176.16MM | $144.71MM |
| Assets | $298.58MM | $205.32MM | $159.56MM |
| Operating Cash Flow | $-57.12MM | $-94.50MM | $-81.23MM |
| Capital expenditure | $7.93MM | $11.61MM | $0.41MM |
| Investing Cash Flow | $-10.44MM | $49.44MM | $110.86MM |
| Financing Cash Flow | $1.93MM | $0.17MM | $48.62MM |
| Earnings Per Share* | $-1.06 | $-2.37 | $-2.05 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.